Segment information

6 Months Ended

Jan. 31, 2017

Segment Reporting [Abstract]

Segment information

15. Segment information

Our business is strategically aligned into three segments: Medical Imaging, Ultrasound, and Security and Detection. Our business segments are described as follows:

• Medical Imaging primarily includes systems and subsystems for CT and MRI medical imaging equipment as well as state-of-the-art, selenium-based detectors for screening of breast cancer and other diagnostic applications in mammography.

• Ultrasound includes ultrasound systems and transducers primarily in the urology, surgery, and point-of-care markets.

• Security and Detection includes advanced threat detecting CT systems utilizing our expertise in advanced imaging technology, primarily used in the checked baggage screening at airports worldwide.

The tables below present information about our reportable segments:

	Three Months Ended						Six Months Ended
	January 31,						January 31,
(in millions)	2017			2016			2017			2016
Product revenue:
Medical Imaging	$	71.2		$	72.4		$	137.7		$	136.8
Ultrasound		40.3			42.6			75.9			79.1
Security and Detection		18.8			10.9			37.0			24.2
Total product revenue	$	130.3		$	125.9		$	250.6		$	240.1
Engineering revenue:
Medical Imaging	$	1.2		$	1.1		$	1.9		$	1.7
Ultrasound		—			0.7			0.2			0.9
Security and Detection		—			0.2			—			0.2
Total engineering revenue	$	1.2		$	2.0		$	2.1		$	2.8
Net revenue:
Medical Imaging	$	72.4		$	73.5		$	139.6		$	138.5
Ultrasound		40.3			43.3			76.1			80.0
Security and Detection		18.8			11.1			37.0			24.4
Total net revenue	$	131.5		$	127.9		$	252.7		$	242.9
Income from operations:
Medical Imaging (A)	$	12.2		$	11.6		$	18.9		$	18.0
Ultrasound (B)		(4.5	)		(9.9	)		(10.3	)		(14.5	)
Security and Detection (C )		1.8			(0.2	)		4.8			—
Total income from operations		9.5			1.5			13.4			3.5
Total other income (loss), net		0.03			(3.5	)		(0.4	)		(4.0	)
Income (loss) before income taxes	$	9.5		$	(2.0	)	$	13.0		$	(0.5	)

	As of		As of
	January 31,		July 31,
(in millions)	2017		2016
Identifiable total assets by segment:
Medical Imaging	$	179.9	$	191.1
Ultrasound		142.2		152.5
Security and Detection		43.3		49.8
Total reportable segment assets		365.4		393.4
Corporate assets (D)		198.9		165.6
Total identifiable assets	$	564.3	$	559.0

(A) Includes restructuring charges of $0.09 million and $1.9 million for three months ended January 31, 2017 and January 31, 2016, respectively and $0.11 million and $4.0 million for six months January 31, 2017 and January 31, 2016.

(B) Includes restructuring charges of $0.17 million and $0.6 million for three months ended January 31, 2017 and January 31, 2016, respectively and $0.18 million and $1.3 million for six months January 31, 2017 and January 31, 2016.

Includes contingent consideration charges of $(8.2) million and $(8.1) million related to Oncura for three and six months ended January 31, 2017, respectively, asset impairment charges of $9.8 million related to Oncura for three and six months ended January 31, 2017, charges for the BK Medical matter of $10.1 million for three and six months ended January 31, 2016.

(C) Includes restructuring charges of $0.01 million and $0.6 million for three months ended January 31, 2017 and January 31, 2016, respectively and $0.01 million and $1.2 million for six months January 31, 2017 and January 31, 2016.

Includes asset impairment charges of $0.6 million related to Pathfinder for three and six months ended January 31, 2017.

(D) Includes cash and cash equivalents of $139.9 million and $97.3 million as of January 31, 2017 and July 31, 2016, respectively.